Mehta 1988.
Methods | Country: United Kingdom Randomisation method: not stated |
|
Participants | Age: 16 to 69 years (20 male, 15 female) 5 groups with 35 participants allocated to each group Inclusion criteria: repeatedly inducible haemodynamically stable SVT (AVNRT or AVRT) Exclusion criteria: unsustainable induced SVT for > 5 minutes, tachyarrhythmias other than AVNRT or AVRT |
|
Interventions | VM performance: 35 mmHg pressure, 15 and 30 seconds duration, supine posture Number of VM attempts: maximum of 2 attempts* for each of 3 episodes of stimulated SVT Group 1: supine VM Group 2: standing VM Group 3: right CSM Group 4: left CSM Group 5: DR |
|
Outcomes | Reversion (in 2 out of 3 attempts). No time frame was given for length of reversion, as these SVT episodes were induced. | |
Notes | * A second attempt was performed if the participant failed to revert on the first attempt. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: "The manoeuvres were performed in random order". "The manoeuvres were performed first during sinus rhythm or first during tachycardia in random order". Comments: Probably not done. |
Allocation concealment (selection bias) | High risk | Not reported. Comment: Probably not done. |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Due to the nature of the interventions participants and personnel could not be blinded. Comment: Not done. |
Blinding of outcome assessment (detection bias) All outcomes | High risk | Not reported. Comment: Probably not done. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Outcomes reported for all interventions (35/35) and outcomes except DR in sinus rhythm (32/35). |
Selective reporting (reporting bias) | Low risk | Outcomes for reversion of SVT for supine and standing VM, right and left CSM, and DR were reported. Heart rate responses in sinus rhythm for the above interventions were also reported. |
Other bias | Unclear risk | N/A |